Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022

被引：0

作者：

Link-Gelles, Ruth ^{[1
]}

Levy, Matthew E. ^{[2
]}

Gaglani, Manjusha ^{[3
,4
]}

Irving, Stephanie A. ^{[5
]}

Stockwell, Melissa ^{[6
,7
,8
]}

Dascomb, Kristin ^{[9
]}

DeSilva, Malini B. ^{[10
]}

Reese, Sarah E. ^{[2
]}

Liao, I-Chia ^{[3
]}

Ong, Toan C. ^{[11
]}

Grannis, Shaun J. ^{[12
,13
]}

McEvoy, Charlene ^{[10
]}

Patel, Palak ^{[1
]}

Klein, Nicola P. ^{[14
]}

Hartmann, Emily ^{[15
]}

Stenehjem, Edward ^{[9
]}

Natarajan, Karthik ^{[8
,16
]}

Naleway, Allison L. ^{[5
]}

Murthy, Kempapura ^{[3
]}

Rao, Suchitra ^{[11
]}

Dixon, Brian E. ^{[12
,17
]}

Kharbanda, Anupam B. ^{[18
]}

Akinseye, Akintunde ^{[2
]}

Dickerson, Monica ^{[1
]}

Lewis, Ned ^{[14
]}

Grisel, Nancy ^{[9
]}

Han, Jungmi ^{[16
]}

Barron, Michelle A. ^{[11
]}

Fadel, William F. ^{[12
,17
]}

Dunne, Margaret M. ^{[2
]}

Goddard, Kristin ^{[14
]}

Arndorfer, Julie ^{[9
]}

Konatham, Deepika ^{[3
]}

Valvi, Nimish R. ^{[12
]}

Currey, J. C. ^{[15
]}

Fireman, Bruce ^{[14
]}

Raiyani, Chandni ^{[3
]}

Zerbo, Ousseny ^{[14
]}

Sloan-Aagard, Chantel ^{[15
,19
]}

Ball, Sarah W. ^{[2
]}

Thompson, Mark G. ^{[1
]}

Tenforde, Mark W. ^{[1
]}

机构：

[1] CDC COVID 19 Emergency Response Team, Atlanta, GA 30333 USA

[2] Westat Corp, Rockville, MD USA

[3] Baylor Scott & White Hlth, Temple, TX USA

[4] Texas A&M Univ, Coll Med, Temple, TX 76508 USA

[5] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA

[6] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pediat, Div Child & Adolescent Hlth, New York, NY 10027 USA

[7] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY USA

[8] New York Presbyterian Hosp, New York, NY USA

[9] Intermt Healthcare, Div Infect Dis & Clin Epidemiol, Salt Lake City, UT USA

[10] Hlth Partners Inst, Minneapolis, MN USA

[11] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA

[12] Regenstrief Inst Hlth Care, Ctr Biomed Informat, Indianapolis, IN USA

[13] Indiana Univ, Sch Med, Indianapolis, IN USA

[14] Kaiser Permanente Vaccine Study Ctr, Kaiser Permanente Northern Calif Div Res, Oakland, CA USA

[15] Paso Norte Hlth Informat Exchange, El Paso, TX USA

[16] Columbia Univ, Irving Med Ctr, Dept Biomed Informat, New York, NY USA

[17] Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA

[18] Childrens Minnesota, Minneapolis, MN USA

[19] Brigham Young Univ, Dept Publ Hlth, Provo, UT 84602 USA

来源：

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2022年 / 71卷 / 29期

关键词：

INFECTION;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：931 / 939

页数：9

共 50 条

[1] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Tseng, Hung Fu
Ackerson, Bradley K.
Bruxvoort, Katia J.
Sy, Lina S.
Tubert, Julia E.
Lee, Gina S.
Ku, Jennifer H.
Florea, Ana
Luo, Yi
Qiu, Sijia
Choi, Soon Kyu
Takhar, Harpreet S.
Aragones, Michael
Paila, Yamuna D.
Chavers, Scott
Talarico, Carla A.
Qian, Lei
NATURE COMMUNICATIONS, 2023, 14 (01)
[2] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Hung Fu Tseng
Bradley K. Ackerson
Katia J. Bruxvoort
Lina S. Sy
Julia E. Tubert
Gina S. Lee
Jennifer H. Ku
Ana Florea
Yi Luo
Sijia Qiu
Soon Kyu Choi
Harpreet S. Takhar
Michael Aragones
Yamuna D. Paila
Scott Chavers
Carla A. Talarico
Lei Qian
Nature Communications, 14
[3] Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
Torres, Carolina
Nabaes Jodar, Mercedes
Acuna, Dolores
Zambrana Montano, Romina Micaela
Alberto Culasso, Andres Carlos
Fernando Amadio, Ariel
Aulicino, Paula
Ceballos, Santiago
Cacciabue, Marco
Debat, Humberto
Dus Santos, Maria Jose
Florencia Eberhardt, Maria
Espul, Carlos
Fay, Fabian
Ailen Fernandez, Maria
Fernandez, Franco
Fernandez Munoz, Juan Manuel
Ferrini, Florencia
Gallego, Fernando
Angelica Giri, Adriana
Cerri, Agustina
Bolatti, Elisa
Ines Gismondi, Maria
Goya, Stephanie
Gramundi, Ivan
Matias Irazoqui, Jose
Alberto Konig, Guido
Leiva, Viviana
Lucero, Horacio
Marquez, Nathalie
Nardi, Cristina
Ortiz, Belen
Pianciola, Luis
Beatriz Pintos, Carolina
Fabiana Puebla, Andrea
Victoria Rastellini, Carolina
Ezequiel Rojas, Alejandro
Sfalcin, Javier
Suarez, Ariel
Tittarelli, Estefania
Toro, Rosana
Vanina Villanova, Gabriela
Cecilia Ziehm, Maria
Carla Zimmermann, Maria
Zunino, Sebastian
Valinotto, Laura
Viegas, Mariana
VIRUSES-BASEL, 2023, 15 (02):
[4] Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022
Surie, Diya
Bonnell, Levi
Adams, Katherine
Gaglani, Manjusha
Ginde, Adit A.
Douin, David J.
Talbot, H. Keipp
Casey, Jonathan D.
Mohr, Nicholas M.
Zepeski, Anne
McNeal, Tresa
Ghamande, Shekhar
Gibbs, Kevin W.
Files, D. Clark
Hager, David N.
Shehu, Arber
Frosch, Anne P.
Erickson, Heidi L.
Gong, Michelle N.
Mohamed, Amira
Johnson, Nicholas J.
Srinivasan, Vasisht
Steingrub, Jay S.
Peltan, Ithan D.
Brown, Samuel M.
Martin, Emily T.
Khan, Akram
Bender, William S.
Duggal, Abhijit
Wilson, Jennifer G.
Qadir, Nida
Chang, Steven Y.
Mallow, Christopher
Rivas, Carolina
Kwon, Jennie H.
Exline, Matthew C.
Lauring, Adam S.
Shapiro, Nathan I.
Halasa, Natasha
Chappell, James D.
Grijalva, Carlos G.
Rice, Todd W.
Stubblefield, William B.
Baughman, Adrienne
Womack, Kelsey N.
Hart, Kimberly W.
Swan, Sydney A.
Zhu, Yuwei
DeCuir, Jennifer
Tenforde, Mark W.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (42): : 1327 - 1334
[5] A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Zhe Chen
Leilei Feng
Lei Wang
Li Zhang
Binyang Zheng
Hua Fu
Fengdi Li
Ligai Liu
Qi Lv
Ran Deng
YanLi Xu
Yongfeng Hu
Jianhua Zheng
Chuan Qin
Linlin Bao
Xiangxi Wang
Qi Jin
Signal Transduction and Targeted Therapy, 10 (1)
[6] COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Delaunay, Charlotte Laniece
Martinez-Baz, Ivan
Seve, Noemie
Domegan, Lisa
Mazagatos, Clara
Buda, Silke
Meijer, Adam
Kislaya', Irina
Pascu, Catalina
Carnahan, Annasara
Oroszi, Beatrix
Ilic, Maja
Maurel, Marine
Melo, Aryse
Martin, Virginia Sandonis
Trobajo-Sanmartin, Camino
Enouf, Vincent
McKenna, Adele
Perez-Gimeno, Gloria
Goerlitz, Luise
de Lange, Marit
Rodrigues, Ana Paula
Lazar, Mihaela
Latorre-Margalef, Neus
Turi, Gergo
Castilla, Jesus
Falchi, Alessandra
Bennett, Charlene
Gallardo, Virtudes
Duerrwald, Ralf
Eggink, Dirk
Guiomar, Raquel
Popescu, Rodica
Riess, Maximilian
Horvath, Judit Krisztina
Casado, Itziar
Garcia, Ma del Carmen
Hooiveld, Mariette
Machado, Ausenda
Bacci, Sabrina
Kaczmarek, Marlena
Kissling, Esther
EUROSURVEILLANCE, 2024, 29 (13)
[7] Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
Kurhade, Chaitanya
Zou, Jing
Xia, Hongjie
Cai, Hui
Yang, Qi
Cutler, Mark
Cooper, David
Muik, Alexander
Jansen, Kathrin U.
Xie, Xuping
Swanson, Kena A.
Shi, Pei-Yong
NATURE COMMUNICATIONS, 2022, 13 (01)
[8] Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
Chaitanya Kurhade
Jing Zou
Hongjie Xia
Hui Cai
Qi Yang
Mark Cutler
David Cooper
Alexander Muik
Kathrin U. Jansen
Xuping Xie
Kena A. Swanson
Pei‑Yong Shi
Nature Communications, 13
[9] Modeling the Prediction on the Efficacy of a Homologous Third Dose of CoronaVac Against SARS-CoV-2 Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5-China, 2020-2021
Chen, Xinhua
Bai, Xufang
Chen, Xinghui
Zheng, Nan
Yang, Juan
Zhang, Juanjuan
Yu, Hongjie
CHINA CDC WEEKLY, 2023, 5 (05): : 103 - +
[10] Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
Maeda, Haruka
Saito, Nobuo
Igarashi, Ataru
Ishida, Masayuki
Terada, Mayumi
Ito, Takayasu
Ikeda, Hideko
Kamura, Hiroshi
Motohashi, Iori
Kimura, Yuya
Komino, Masaru
Arai, Hiromi
Kuwamitsu, Osamu
Akuzawa, Nobuhiro
Sando, Eiichiro
Morikawa, Toru
Imura, Haruki
Inoue, Hiroki
Hayakawa, Tomoichiro
Teshigahara, Osamu
Ohara, Yasuji
Suzuki, Motoi
Morimoto, Konosuke
EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 288 - 298

← 1 2 3 4 5 →